NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.44 Cr | ₹0.10 Cr | ₹0.28 Cr | ₹0.28 Cr | ₹0.30 Cr |
What is the latest Contingent Liabilities ratio of NGL FINECHEM ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.44 Cr |
Mar2023 | ₹0.10 Cr |
Mar2022 | ₹0.28 Cr |
Mar2021 | ₹0.28 Cr |
Mar2020 | ₹0.30 Cr |
How is Contingent Liabilities of NGL FINECHEM Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.44 Cr | 336.63 | |
Mar2023 | ₹0.10 Cr | -63.67 | |
Mar2022 | ₹0.28 Cr | 0.00 | |
Mar2021 | ₹0.28 Cr | -6.40 | |
Mar2020 | ₹0.30 Cr | - |
Compare Contingent Liabilities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹700.3 Cr | 4.6% | -2% | -57.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹427,406.0 Cr | -2.7% | 3.9% | 19.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,113.0 Cr | 1% | 8.5% | 55.3% | Stock Analytics | |
CIPLA | ₹121,869.0 Cr | -2.6% | 3.9% | 6.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,345.0 Cr | -0.7% | 2.5% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,801.0 Cr | -1.9% | 0.9% | -7.8% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 4.6% |
-2% |
-57.5% |
SENSEX | 0.6% |
6.2% |
8.4% |
You may also like the below Video Courses